MBiotech Awards Recognize Innovation

Wednesday, April 17, 2013 - 1:00pm

The Master of Biotechnology Program at the University of Toronto Mississauga (MBiotech) recently handed out their annual MBiotech “Innovator Awards”. These are given to the student teams who presented the most innovative projects in Biotech in Medicine, Supervised Studies, and/or the AstraZeneca Seminar Series. All projects were supervised by Dr. Jayson Parker.

Team NovoVitFirst place overall for 2012-2013 went to Team NovoVit for their Code Orange Software. With hospital resources being stretched all across the country, and Code Orange emergencies currently managed through a slow and cumbersome paper-based process, The NovoVit Group saw an opportunity to employ new technological solutions. After speaking to many industry experts, entrepreneurs and performing extensive market research on the opportunity for emergency management software in Canadian hospitals, the team began negotiations with a leading U.S. firm to discuss the possibility of leading the market entry of their software to Canadian hospitals. The team is currently engaged in ongoing discussions with their potential future partner, developing a business plan and is currently vetting candidates for a part-time Vice President of Sales position to be the main point of contact with hospitals in the future.

Team SciQureSecond place went to Team SciQure, who presented an opportunity based on the need for more efficient narcotic tracking in long term care facilities. The team presented a proposal for narcotic tracking software, designed to replace the current paper-based system for narcotics management in long-term care facilities. They have attracted the interest of senior management of the dominant U.S. firm in this area, and are now in discussions re: partnering and licensing.

A final award was presented to Team 4SITE, who set out to find an innovative way to increase sales for Medtronic’s insulin pump product line. Upon interviewing patients and studying the U.S. regulatory filings at the FDA, the students proposed displaying blood glucose readings on a smartphone so that patients could discretely monitor their glucose readings in a public place. A senior representative from Medtronic, one of the largest medical device manufacturers in the world, attended the talk and invited Dr. Parker and the students to review the proposal with the entire senior management team of Medtronic in Canada. Subsequently, Johnson & Johnson also requested to view the proposal as they also offer an insulin pump product line.

The MBiotech Program is a 24 month, course-based professional master's degree at the University of Toronto Mississauga which incorporates both science and business courses with 8 to 12 months of work experience in industry. For more information, please visit www.mbiotech.ca